Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2025
5-1-2025 Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the American College of Radiology and the American Academy of Allergy, Asthma & Immunology, Carolyn Wang, Department of Radiology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195., Allison Ramsey, Rochester Regional Health, David Lang, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio., et al.
5-1-2025 Safety and Efficacy of Dupilumab in Adults and Adolescents With Asthma in the RAPID Registry, N L. Lugogo, A T. Peters, O Hilberg, et al.
4-1-2025 Infant and Toddler Peanut Oral Immunotherapy: Initiation Before Age 2 Increases Ad Libitum Peanut Consumption, S Shahzad Mustafa, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Linh-An Tuong, Rochester Regional Health, et al.
3-13-2025 Purification and Epitope Mapping of Jug r 4, a Major Walnut Allergen, Stephen A. Gipson, Jacqueline B. Nesbit, Lauren T. Swientoniewski, et al.
3-1-2025 A second look at secondary hypogammaglobulinemia, Rose Monahan, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California San Francisco Medical Center, San Francisco, California., Iris M. Otani, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California San Francisco Medical Center, San Francisco, California., Heather K. Lehman, Division of Allergy, Immunology, and Rheumatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York., et al.
3-1-2025 Patient-reported outcomes with subcutaneous immunoglobulin in secondary immunodeficiency, Juthaporn Cowan, Department of Medicine, Division of Infectious Diseases, University of Ottawa, Ottawa, ON, Canada., Il-Kang Na, Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., André Gladiator, Global Medical Affairs, Takeda Pharmaceuticals International AG, Zurich, Switzerland., et al.
2-1-2025 Characterization of Real World Food Allergy Management Choices, Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Sara Patrawala, Rochester Regional Health, et al.
2-1-2025 Enhancing Peanut and Tree Nut Allergy Diagnostics Using Linear and Conformational IgE Epitopes of Vicilin-Buried Peptides, Lauren Swientoniewski, Ian Rambo, Jacqueline Nesbit, et al.
2-1-2025 Health-related quality of life and treatment satisfaction in pediatric patients with hypogammaglobulinemia treated with subcutaneous versus intravenous immunoglobulin replacement therapy, Kevin Ackerman, Peter Capucilli, Rochester Regional Health, Jennifer Heimall, et al.
2-1-2025 Higher Prevalence of Humoral Immunodeficiency in Patients with Severe COPD, Ruth Agwaze; Allison Ramsey, Rochester Regional Health; and S Shahzad Mustafa, Rochester Regional Health
2-1-2025 Obstetric penicillin allergy evaluations, Lakshmi G. Nair; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health
2-1-2025 Safety and Efficacy of Outpatient Drug Challenges, Unaiza Faizan, Rochester Regional Health, Shiamak Cooper, Rochester Regional Health, Alshaima Yousef, Rochester Regional Health, et al.
2-1-2025 Steroid stewardship in allergy/immunology: An opportunity for improved clinical outcomes, Sara Patrawala, Rochester Regional Health; Allison Ramsey, Rochester Regional Health; and S Shahzad Mustafa, Rochester Regional Health
2-1-2025 The Safety And Efficacy Of Dupilumab In A Real-World Clinical Setting: The RAPID Asthma Prospective Registry, Anju Peters, Ole Hilberg, Njira Lugogo, et al.
1-29-2025 Hypersensitivity Reactions to Anticonvulsants, Unaiza Faizan, Rochester Regional Health and Allison Ramsey, Rochester Regional Health
1-1-2025 Development and acceptability of a decision-aid for food allergy oral immunotherapy in children, Aikaterini Anagnostou, Elissa M. Abrams, Melanie Carver, et al.
Submissions from 2024
12-1-2024 AAAAI Position Statement on Changing Electronic Health Record Allergy Documentation to "Alerts" to Lead to Easily Understood, Actionable Labels, Andrew A. White, Scripps Clinic, La Jolla, Calif., Allison Ramsey, Rochester Regional Health, Autumn Guyer, Memorial Sloan Kettering Cancer Center, New York, NY., et al.
12-1-2024 Improving Adherence in Allergy Care: Challenges and Solutions, Allison C. Ramsey, Rochester Regional Health and Jay M. Portnoy, Division of Allergy, Immunology, Pulmonary and Sleep Medicine. Children's Mercy Hospital, Kansas City, Mo.
11-1-2024 Role of an embedded health system specialty pharmacy on prescription of biologics in allergy/immunology, Sara Patrawala, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health
10-17-2024 Management of Asthma (and More) with Biologics, S Shahzad Mustafa, Rochester Regional Health
10-1-2024 Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis, Claus Bachert, University Hospital of Münster, Münster, Germany., Philippe Gevaert, Ghent University, Ghent, Belgium., Brian Lipworth, University of Dundee, Dundee, UK., et al.
10-1-2024 Transitions of Care in Patients With Inborn Errors of Immunity, Benjamin T. Prince, Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio., Amy Garee, Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio., Anne Marie Holly, Rochester Regional Health, et al.
9-1-2024 A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology, Jay A. Lieberman, Department of Pediatrics, The University of Tennessee Health Science Center and LeBonheur Children's Hospital, Memphis, Tennessee., Derek K. Chu, Departments of Medicine and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; Evidence in Allergy Group, McMaster University and The Research Institute of St. Joe's Hamilton, Hamilton, Canada., Tasnuva Ahmed, Department of Health Research Methods, Evidence, and Impact, Evidence in Allergy Group, McMaster University, Hamilton, Canada., et al.
9-1-2024 Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?, Alessandro Fiocchi, Bambino Gesù Childrens' Hospital IRCCS, Rome, Italy., R Sharon Chinthrajah, Stanford University, Stanford, CA, USA., Ignacio J. Ansotegui, Hospital Quironsalud Bizkaia, Bilbao, Spain., et al.
8-1-2024 Infant anaphylaxis and epinephrine use: Can we improve acute management?, Aikaterini Anagnostou, Matthew Greenhawt, S Shahzad Mustafa, Rochester Regional Health, et al.